Skeletal muscle index/systemic immune-inflammation index (SMI/SII) ratio predicts prognosis in patients with hepatocellular carcinoma
A decreased SMI/SII may be a distinct biomarker of unfavorable prognosis in patients with HCCs, which may be practical to develop personalized treatment strategies for HCC.
Authors
- Tian-Zhi An
- Huizhou Li
- Shu-Xian Li
- Tian-Cheng Wang (ORCID: https://orcid.org/0000-0002-5908-2771)
- Yu‐Dong Xiao (ORCID: https://orcid.org/0000-0002-6815-3447)
- Jun‐Xiang Li
- Wei Huang (ORCID: https://orcid.org/0009-0005-0593-830X)
- Chao Hu (ORCID: https://orcid.org/0009-0008-7512-5875)
Institutions
- Central South University (CN)
- Guiyang Medical University (CN)
- Guizhou Cancer Hospital (CN)
- Affiliated Hospital of Guizhou Medical University (CN)
- Hunan Cancer Hospital (CN)
- Second Xiangya Hospital of Central South University (CN)
- Xiangya Hospital Central South University (CN)
Publication Details
- Journal
- World Journal of Surgical Oncology
- Published
- 2025-05-04
- DOI
- https://doi.org/10.1186/s12957-025-03826-x
- Citations
- 1
- Primary Topic
- Inflammatory Biomarkers in Disease Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 1.05
Funders
- Central South University
- Natural Science Foundation of Hunan Province
- Fundamental Research Funds for the Central Universities
- Fundamental Research Funds for Central Universities of the Central South University